Recombinant humanized (from mouse) antibody expressed in CHO binding to human SELL/CD62L. Aselizumab is an immunosuppressive drug which has been investigated for the use in severely injured patients.
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Mouse
- Derivation
- Humanized (from mouse)
- Type
- IgG4
- Species Reactivity
- Human
- Applications
- Suitable for use in FC, IP, ELISA, Neut, FuncS, IF, WB and most other immunological methods.
- CAS
- 395639-53-9
- Generic Name
- aselizumab
- Related Disease
- Unknown
Author Profile
Latest entries
Tech30/08/2023Anti-CD3E Recombinant Antibody (Visilizumab) (CAT#: TAB-714)
Tech30/08/2023Anti-SLAMF7 Recombinant Antibody (Elotuzumab) (CAT#: TAB-743)
Tech30/08/2023Anti-Human MUC1 Recombinant Antibody (Sontuzumab) (CAT#: TAB-H65)
Tech30/08/2023Anti-SELL/CD62L Recombinant Antibody (Aselizumab) (CAT#: TAB-720)
